These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22531442)

  • 1. Marketed therapeutic antibodies compendium.
    Reichert JM
    MAbs; 2012; 4(3):413-5. PubMed ID: 22531442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development trends for human monoclonal antibody therapeutics.
    Nelson AL; Dhimolea E; Reichert JM
    Nat Rev Drug Discov; 2010 Oct; 9(10):767-74. PubMed ID: 20811384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets.
    Bugelski PJ; Martin PL
    Br J Pharmacol; 2012 Jun; 166(3):823-46. PubMed ID: 22168282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic monoclonal antibodies in ophthalmology.
    Rodrigues EB; Farah ME; Maia M; Penha FM; Regatieri C; Melo GB; Pinheiro MM; Zanetti CR
    Prog Retin Eye Res; 2009 Mar; 28(2):117-44. PubMed ID: 19114125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Off-label use of biologic agents in the treatment of dermatosis, part 2: etanercept, efalizumab, alefacept, rituximab, daclizumab, basiliximab, omalizumab, and cetuximab].
    Guhl G; Díaz-Ley B; Fernández-Herrera J
    Actas Dermosifiliogr; 2008; 99(1):5-33. PubMed ID: 18206084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
    BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A BRIEF SYNOPSIS OF MONOCLONAL ANTIBODY FOR THE TREATMENT OF VARIOUS GROUPS OF DISEASES.
    Puthenpurail A; Rathi H; Nauli SM; Ally A
    World J Pharm Pharm Sci; 2021 Nov; 10(11):14-22. PubMed ID: 35071113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets.
    Martin PL; Bugelski PJ
    Br J Pharmacol; 2012 Jun; 166(3):806-22. PubMed ID: 22168335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies in the treatment of cancer, Part 1.
    Cersosimo RJ
    Am J Health Syst Pharm; 2003 Aug; 60(15):1531-48. PubMed ID: 12951753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Certolizumab pegol: new drug. As a last resort in Crohn's disease: continue to use other TNF alpha inhibitors.
    Prescrire Int; 2009 Jun; 18(101):108-10. PubMed ID: 19637418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies in the treatment of cancer, Part 2.
    Cersosimo RJ
    Am J Health Syst Pharm; 2003 Aug; 60(16):1631-41; quiz 1642-3. PubMed ID: 12966906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic monoclonal antibodies: trends in development and approval in the US.
    Reichert JM
    Curr Opin Mol Ther; 2002 Apr; 4(2):110-8. PubMed ID: 12044031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of Monoclonal Antibodies Throughout Pregnancy: A Systematic Literature Review.
    van Gendt J; Emaus R; Visschedijk MC; Touw DJ; Bouwknegt DG; de Leeuw K; Prins JR; Malik P; Mian P
    Clin Pharmacokinet; 2024 May; 63(5):589-622. PubMed ID: 38583128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic monoclonal antibody market.
    Ecker DM; Jones SD; Levine HL
    MAbs; 2015; 7(1):9-14. PubMed ID: 25529996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New frontiers in oncology: biosimilar monoclonal antibodies for the treatment of breast cancer.
    Thill M
    Expert Rev Anticancer Ther; 2015 Mar; 15(3):331-8. PubMed ID: 25539719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bispecific antibodies for cancer therapy: the light at the end of the tunnel?
    Chames P; Baty D
    MAbs; 2009; 1(6):539-47. PubMed ID: 20073127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis.
    Ternant D; Bejan-Angoulvant T; Passot C; Mulleman D; Paintaud G
    Clin Pharmacokinet; 2015 Nov; 54(11):1107-23. PubMed ID: 26123705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of monoclonal antibodies in cancer therapy: present and promise.
    Stern M; Herrmann R
    Crit Rev Oncol Hematol; 2005 Apr; 54(1):11-29. PubMed ID: 15780905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biologic therapies in the treatment of psoriasis].
    Farhi D; Dupin N
    Presse Med; 2009 May; 38(5):832-43. PubMed ID: 19282134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.